MAKE A DONATION
Crime and Incidents
Thinking About China
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
Business & Economy
China Human Rights
Organ Harvesting in China
Asia & Pacific
Business & Markets
Gold and Commodities
ARTS & CULTURE
Fine Arts & Craftsmanship
Shen Yun Special Coverage
Film & TV
Tech Products & Reviews
American Thought Leaders
Family & Education
Film & TV
Life & Wellness
FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe
The U.S. Food and Drug Administration's (FDA) approval process of the controversial and costly new Alzheimer’s drug Aduhelm was "rife with irregularities" and "highly atypical," according to a report released on Dec. 29 by the House ...
December 30, 2022
Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug
President Joe Biden on Tuesday touted a decline in costs for tens of millions of Americans covered by the ...
September 28, 2022
FDA Finally Approved an Alzheimer’s Drug—But Everything Surrounding It Is Controversial
Analysis Aduhelm is the brand name under which the Alzheimer’s drug Aducanumab is marketed. It is developed by ...
August 20, 2022
Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn
Medicare could potentially waste up to $605 million annually from the packaging of controversial Alzheimer’s drug aducanumab if ...
July 6, 2022
Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm
Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is ...
May 4, 2022
Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials
Medicare will only cover a drug for Alzheimer's disease for patients in clinical trials, President Joe Biden's administration ...
April 8, 2022
Biden Administration Decides to Limit Medicare Coverage of New Alzheimer’s Drug
Medicare will only cover a new Alzheimer's drug that costs $28,000 a year for patients who are enrolled ...
January 11, 2022
CMS May Review Medicare Premium in Light of Aduhelm Price Drop
President Joe Biden's administration is considering a reassessment of Medicare Part B premiums after the drugmaker behind a ...
January 10, 2022
Biogen Halves Price of Alzheimer’s Drug to $28,200
Biogen Inc. on Monday cut the price of its Alzheimer's drug by about half to $28,200 for an ...
December 20, 2021
Theater Review: ‘West Side Story’: A Stunning Revival
New Hampshire Gov. Sununu Won’t Run for President in 2024
Savannah Hulsey Pointer
[PREMIERING 7:00PM ET] This Is the Real Reason Companies Are Going Woke
WHO Adopts European-Style COVID-19 Vaccine Passports as Part of New Global Digital Health Certificate
Jim Hines, First Man to Run 100 Meters in Under 10 Seconds, Dies Aged 76
‘Rogue’ FBI Conduct Sparks Protest at Federal Building in Detroit
Lifestyle: Grilling: It's All About the Sauce—and the Seeds
Operation Mountain Storm 2004: The Forgotten Female Searchers
Biden Draws Bipartisan Ire for Leaving 3 Key Watchdog Jobs Vacant for More Than 2 Years
White House Decries Chinese Military’s ‘Growing Aggressiveness’